• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于荧光偏振的高通量筛选技术发现新型心肌肌钙蛋白激活剂。

Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays.

机构信息

Randall Centre for Cell and Molecular Biophysics, King's College London, London, SE1 1UL, UK.

British Heart Foundation Centre of Research Excellence, King's College London, London, SE1 1UL, UK.

出版信息

Sci Rep. 2023 Mar 30;13(1):5216. doi: 10.1038/s41598-023-32476-w.

DOI:10.1038/s41598-023-32476-w
PMID:36997544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10063609/
Abstract

The large unmet demand for new heart failure therapeutics is widely acknowledged. Over the last decades the contractile myofilaments themselves have emerged as an attractive target for the development of new therapeutics for both systolic and diastolic heart failure. However, the clinical use of myofilament-directed drugs has been limited, and further progress has been hampered by incomplete understanding of myofilament function on the molecular level and screening technologies for small molecules that accurately reproduce this function in vitro. In this study we have designed, validated and characterized new high throughput screening platforms for small molecule effectors targeting the interactions between the troponin C and troponin I subunits of the cardiac troponin complex. Fluorescence polarization-based assays were used to screen commercially available compound libraries, and hits were validated using secondary screens and orthogonal assays. Hit compound-troponin interactions were characterized using isothermal titration calorimetry and NMR spectroscopy. We identified NS5806 as novel calcium sensitizer that stabilizes active troponin. In good agreement, NS5806 greatly increased the calcium sensitivity and maximal isometric force of demembranated human donor myocardium. Our results suggest that sarcomeric protein-directed screening platforms are suitable for the development of compounds that modulate cardiac myofilament function.

摘要

人们普遍认识到,治疗心力衰竭的新疗法存在巨大的未满足需求。在过去几十年中,收缩性肌丝本身已成为开发治疗收缩性和舒张性心力衰竭新疗法的有吸引力的靶点。然而,肌丝靶向药物的临床应用受到限制,由于对肌丝功能在分子水平上的不完全了解以及用于体外准确再现这种功能的小分子筛选技术,进一步的进展受到了阻碍。在这项研究中,我们设计、验证和表征了针对心脏肌钙蛋白复合物中肌钙蛋白 C 和肌钙蛋白 I 亚基相互作用的新型小分子效应物的高通量筛选平台。使用荧光偏振测定法筛选市售的化合物文库,并使用二次筛选和正交测定法验证命中物。使用等温滴定量热法和 NMR 光谱法表征命中化合物与肌钙蛋白的相互作用。我们确定 NS5806 是一种新型的钙敏化剂,可稳定活性肌钙蛋白。一致的是,NS5806 极大地增加了去垢剂处理的人供体心肌的钙敏感性和最大等长力。我们的结果表明,肌节蛋白靶向筛选平台适合开发调节心肌肌丝功能的化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/75c3f6844bbd/41598_2023_32476_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/8059e7db5d52/41598_2023_32476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/797daa918af9/41598_2023_32476_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/caa58f683993/41598_2023_32476_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/922c5562e963/41598_2023_32476_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/1ee5071b1c26/41598_2023_32476_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/75c3f6844bbd/41598_2023_32476_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/8059e7db5d52/41598_2023_32476_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/797daa918af9/41598_2023_32476_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/caa58f683993/41598_2023_32476_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/922c5562e963/41598_2023_32476_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/1ee5071b1c26/41598_2023_32476_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ca4/10063609/75c3f6844bbd/41598_2023_32476_Fig6_HTML.jpg

相似文献

1
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays.基于荧光偏振的高通量筛选技术发现新型心肌肌钙蛋白激活剂。
Sci Rep. 2023 Mar 30;13(1):5216. doi: 10.1038/s41598-023-32476-w.
2
High Throughput Screen Identifies Small Molecule Effectors That Modulate Thin Filament Activation in Cardiac Muscle.高通量筛选鉴定小分子效应物调节心肌细肌丝激活。
ACS Chem Biol. 2021 Jan 15;16(1):225-235. doi: 10.1021/acschembio.0c00908. Epub 2020 Dec 14.
3
Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen.在高通量荧光寿命筛选中鉴定出的化合物可抑制肌球蛋白结合蛋白 C 与肌动蛋白的相互作用。
J Biol Chem. 2021 Jul;297(1):100840. doi: 10.1016/j.jbc.2021.100840. Epub 2021 May 28.
4
Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach.新型小分子肌钙蛋白 C 钙敏剂的发现:一种结合虚拟和实验筛选方法。
J Chem Inf Model. 2020 Jul 27;60(7):3648-3661. doi: 10.1021/acs.jcim.0c00452. Epub 2020 Jul 7.
5
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.蛋白激酶D是心肌肌钙蛋白I磷酸化的新型介质,并调节肌丝功能。
Circ Res. 2004 Nov 26;95(11):1091-9. doi: 10.1161/01.RES.0000149299.34793.3c. Epub 2004 Oct 28.
6
Functional analysis of troponin I regulatory domains in the intact myofilament of adult single cardiac myocytes.成年单个心肌细胞完整肌丝中肌钙蛋白I调节结构域的功能分析。
J Biol Chem. 1999 Aug 6;274(32):22508-16. doi: 10.1074/jbc.274.32.22508.
7
Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I.肌球蛋白调节轻链激酶通过磷酸化肌球蛋白调节轻链和肌钙蛋白 I 来调节心肌收缩力。
J Biol Chem. 2020 Apr 3;295(14):4398-4410. doi: 10.1074/jbc.RA119.011945. Epub 2020 Feb 21.
8
Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.长度依赖性激活受肌钙蛋白 I 丝氨酸 23 和丝氨酸 24 的双磷酸化调节,但不受 Thr143 磷酸化调节。
Am J Physiol Heart Circ Physiol. 2014 Apr 15;306(8):H1171-81. doi: 10.1152/ajpheart.00580.2013. Epub 2014 Feb 28.
9
Structural and functional impact of troponin C-mediated Ca sensitization on myofilament lattice spacing and cross-bridge mechanics in mouse cardiac muscle.肌钙蛋白 C 介导的钙敏化对小鼠心肌肌丝晶格间距和横桥力学的结构和功能影响。
J Mol Cell Cardiol. 2018 Oct;123:26-37. doi: 10.1016/j.yjmcc.2018.08.015. Epub 2018 Aug 21.
10
Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?挑战与心肌病相关的当前范式。含有心肌肌钙蛋白C突变(G159D和L29Q)的肌丝钙敏感性变化能否很好地预测表型结果?
J Biol Chem. 2008 Nov 28;283(48):33119-28. doi: 10.1074/jbc.M804070200. Epub 2008 Sep 26.

引用本文的文献

1
Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies.控制心脏张力机制的新观念:聚焦家族性扩张型心肌病(DCM)和针对肌节的治疗方法
Biomedicines. 2024 May 2;12(5):999. doi: 10.3390/biomedicines12050999.
2
Synthesis and Biophysical Characterization of Fingolimod Derivatives as Cardiac Troponin Antagonists.作为心肌肌钙蛋白拮抗剂的芬戈莫德衍生物的合成与生物物理特性研究
ACS Med Chem Lett. 2024 Feb 7;15(3):413-417. doi: 10.1021/acsmedchemlett.3c00511. eCollection 2024 Mar 14.
3
Discovery of a novel cardiac-specific myosin modulator using artificial intelligence-based virtual screening.

本文引用的文献

1
Sarcomere length affects Ca2+ sensitivity of contraction in ischemic but not non-ischemic myocardium.肌节长度影响缺血但不影响非缺血心肌收缩的钙离子敏感性。
J Gen Physiol. 2023 Mar 6;155(3). doi: 10.1085/jgp.202213200. Epub 2023 Jan 12.
2
Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.小分子RPI-194可稳定激活的肌钙蛋白,以增加横纹肌收缩的钙敏感性。
Front Physiol. 2022 Jun 8;13:892979. doi: 10.3389/fphys.2022.892979. eCollection 2022.
3
FDA approves first cardiac myosin inhibitor.
利用基于人工智能的虚拟筛选发现新型心脏特异性肌球蛋白调节剂。
Nat Commun. 2023 Nov 24;14(1):7692. doi: 10.1038/s41467-023-43538-y.
美国食品药品监督管理局批准首款心肌肌凝蛋白抑制剂。
Nat Rev Drug Discov. 2022 Jun;21(6):406. doi: 10.1038/d41573-022-00087-1.
4
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.米力农或多巴酚丁胺用于心力衰竭患者:荟萃分析证据
ESC Heart Fail. 2022 Jun;9(3):2049-2050. doi: 10.1002/ehf2.13812. Epub 2022 Apr 5.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
6
Structural and Thermodynamic Model for the Activation of Cardiac Troponin.心脏肌钙蛋白激活的结构与热力学模型。
Biochemistry. 2022 Apr 19;61(8):741-748. doi: 10.1021/acs.biochem.2c00084. Epub 2022 Mar 29.
7
Targeting the sarcomere in inherited cardiomyopathies.靶向遗传性心肌病中的肌节。
Nat Rev Cardiol. 2022 Jun;19(6):353-363. doi: 10.1038/s41569-022-00682-0. Epub 2022 Mar 18.
8
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
9
Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics.新型小分子肌钙蛋白激活剂增加心肌收缩功能而不影响能量代谢。
Circ Heart Fail. 2022 Mar;15(3):e009195. doi: 10.1161/CIRCHEARTFAILURE.121.009195. Epub 2021 Nov 8.
10
Current and emerging drug targets in heart failure treatment.心力衰竭治疗中的现有和新兴药物靶点。
Heart Fail Rev. 2022 Jul;27(4):1119-1136. doi: 10.1007/s10741-021-10137-2. Epub 2021 Jul 17.